Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Characteristics of human primary mantle cell lymphoma engraftment in NSG mice.

Iyengar S, Ariza-McNaughton L, Clear A, Taussig D, Auer R, Roe A, Lillington D, Iqbal S, Joel S, Gribben J, Bonnet D.

Br J Haematol. 2016 Apr;173(1):165-9. doi: 10.1111/bjh.13581. Epub 2015 Jul 28. No abstract available.

2.

Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation.

Miraki-Moud F, Anjos-Afonso F, Hodby KA, Griessinger E, Rosignoli G, Lillington D, Jia L, Davies JK, Cavenagh J, Smith M, Oakervee H, Agrawal S, Gribben JG, Bonnet D, Taussig DC.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13576-81. doi: 10.1073/pnas.1301891110. Epub 2013 Jul 30.

3.

Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse.

Montoto S, Matthews J, Greaves P, Lillington D, Anderson D, Gribben JG, Lister TA.

Haematologica. 2013 Apr;98(4):620-5. doi: 10.3324/haematol.2012.069583. Epub 2012 Nov 9.

4.

Amplification of the G allele at SNP rs6983267 in 8q24 amplicons in myeloid malignancies as cause of the lack of MYC overexpression?

Micale L, Augello B, Daniele G, Macchia G, L'abbate A, Muehlematter D, Vandenberghe P, Johansson B, Cabrol C, Solé F, Dastugue N, Slovak ML, Lillington D, Raynaud S, Lafage M, Nacheva ED, Merla G, Storlazzi CT.

Blood Cells Mol Dis. 2011 Dec 15;47(4):259-61. doi: 10.1016/j.bcmd.2011.09.001. Epub 2011 Sep 25. No abstract available.

PMID:
21945030
5.

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.

Taussig DC, Vargaftig J, Miraki-Moud F, Griessinger E, Sharrock K, Luke T, Lillington D, Oakervee H, Cavenagh J, Agrawal SG, Lister TA, Gribben JG, Bonnet D.

Blood. 2010 Mar 11;115(10):1976-84. doi: 10.1182/blood-2009-02-206565. Epub 2010 Jan 6.

6.

Advanced preparative techniques to establish probes for molecular cytogenetics.

Stap J, Aten JA, Lillington D, Shelling A, Young BD.

Curr Protoc Cytom. 2001 May;Chapter 8:Unit 8.6. doi: 10.1002/0471142956.cy0806s05.

PMID:
18770744
7.

Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells.

Taussig DC, Miraki-Moud F, Anjos-Afonso F, Pearce DJ, Allen K, Ridler C, Lillington D, Oakervee H, Cavenagh J, Agrawal SG, Lister TA, Gribben JG, Bonnet D.

Blood. 2008 Aug 1;112(3):568-75. doi: 10.1182/blood-2007-10-118331. Epub 2008 Jun 3.

8.

Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia.

Raghavan M, Smith LL, Lillington DM, Chaplin T, Kakkas I, Molloy G, Chelala C, Cazier JB, Cavenagh JD, Fitzgibbon J, Lister TA, Young BD.

Blood. 2008 Aug 1;112(3):814-21. doi: 10.1182/blood-2008-01-132431. Epub 2008 May 19.

9.

WTX is rarely mutated in acute myeloid leukemia.

Owen C, Virappane P, Alikian M, Stasevich I, Summers K, Lillington D, Bonnet D, Burnett A, Mills K, Lister TA, Fitzgibbon J.

Haematologica. 2008 Jun;93(6):947-8. doi: 10.3324/haematol.12509. Epub 2008 May 6. No abstract available.

10.

Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease.

Paulsson K, Cazier JB, Macdougall F, Stevens J, Stasevich I, Vrcelj N, Chaplin T, Lillington DM, Lister TA, Young BD.

Proc Natl Acad Sci U S A. 2008 May 6;105(18):6708-13. doi: 10.1073/pnas.0800408105. Epub 2008 May 5.

11.

Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia.

Agrawal SG, Liu FT, Wiseman C, Shirali S, Liu H, Lillington D, Du MQ, Syndercombe-Court D, Newland AC, Gribben JG, Jia L.

Blood. 2008 Mar 1;111(5):2790-6. Epub 2007 Dec 26.

12.

Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.

Haferlach C, Rieder H, Lillington DM, Dastugue N, Hagemeijer A, Harbott J, Stilgenbauer S, Knuutila S, Johansson B, Fonatsch C.

Genes Chromosomes Cancer. 2007 May;46(5):494-9.

PMID:
17311250
13.

Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).

Akasaka T, Balasas T, Russell LJ, Sugimoto KJ, Majid A, Walewska R, Karran EL, Brown DG, Cain K, Harder L, Gesk S, Martin-Subero JI, Atherton MG, Brüggemann M, Calasanz MJ, Davies T, Haas OA, Hagemeijer A, Kempski H, Lessard M, Lillington DM, Moore S, Nguyen-Khac F, Radford-Weiss I, Schoch C, Struski S, Talley P, Welham MJ, Worley H, Strefford JC, Harrison CJ, Siebert R, Dyer MJ.

Blood. 2007 Apr 15;109(8):3451-61. Epub 2006 Dec 14.

14.

A role for mitotic recombination in leukemogenesis.

Young BD, Debernardi S, Lillington DM, Skoulakis S, Chaplin T, Foot NJ, Raghavan M.

Adv Enzyme Regul. 2006;46:90-7. Epub 2006 Aug 4. Review. No abstract available.

PMID:
16890980
15.

Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias.

Fitzgibbon J, Smith LL, Raghavan M, Smith ML, Debernardi S, Skoulakis S, Lillington D, Lister TA, Young BD.

Cancer Res. 2005 Oct 15;65(20):9152-4.

16.

Differential gene expression in pituitary adenomas by oligonucleotide array analysis.

Morris DG, Musat M, Czirják S, Hanzély Z, Lillington DM, Korbonits M, Grossman AB.

Eur J Endocrinol. 2005 Jul;153(1):143-51.

PMID:
15994756
17.

Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias.

Raghavan M, Lillington DM, Skoulakis S, Debernardi S, Chaplin T, Foot NJ, Lister TA, Young BD.

Cancer Res. 2005 Jan 15;65(2):375-8.

18.

BCL2 and JUNB abnormalities in primary cutaneous lymphomas.

Mao X, Orchard G, Lillington DM, Child FJ, Vonderheid EC, Nowell PC, Bagot M, Bensussan A, Russell-Jones R, Young BD, Whittaker SJ.

Br J Dermatol. 2004 Sep;151(3):546-56.

PMID:
15377339
19.

Understanding cancer at the chromosome level: 40 years of progress.

Debernardi S, Lillington D, Young BD.

Eur J Cancer. 2004 Sep;40(13):1960-7.

PMID:
15315804
20.

Molecular cloning of a constitutional t(7;22) translocation associated with risk of hematological malignancy.

Hill AS, MacCallum PK, Young BD, Lillington DM.

Genes Chromosomes Cancer. 2003 Nov;38(3):260-4.

PMID:
14506701
21.

Genomic alterations in blastic natural killer/extranodal natural killer-like T cell lymphoma with cutaneous involvement.

Mao X, Onadim Z, Price EA, Child F, Lillington DM, Russell-Jones R, Young BD, Whittaker S.

J Invest Dermatol. 2003 Sep;121(3):618-27.

22.

Expression profile of wild-type ETV6 in childhood acute leukaemia.

Patel N, Goff LK, Clark T, Ford AM, Foot N, Lillington D, Hing S, Pritchard-Jones K, Jones LK, Saha V.

Br J Haematol. 2003 Jul;122(1):94-8.

PMID:
12823350
23.

Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma.

Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker S.

Genes Chromosomes Cancer. 2003 Jun;37(2):176-85.

PMID:
12696066
24.

Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events.

Debernardi S, Lillington DM, Chaplin T, Tomlinson S, Amess J, Rohatiner A, Lister TA, Young BD.

Genes Chromosomes Cancer. 2003 Jun;37(2):149-58.

PMID:
12696063
25.

Molecular cytogenetic characterization of Sézary syndrome.

Mao X, Lillington DM, Czepulkowski B, Russell-Jones R, Young BD, Whittaker S.

Genes Chromosomes Cancer. 2003 Mar;36(3):250-60. Review.

PMID:
12557225
26.

Comparative genomic hybridization and multiplex-fluorescence in situ hybridization: an appraisal in elderly patients with acute myelogenous leukemia.

Dalley CD, Neat MJ, Foot NJ, Burridge M, Byrne L, Amess JA, Rohatiner AZ, Lister A, Young BD, Lillington DM.

Hematol J. 2002;3(6):290-8.

PMID:
12522451
27.

Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome.

Lillington DM, Kingston JE, Coen PG, Price E, Hungerford J, Domizio P, Young BD, Onadim Z.

Genes Chromosomes Cancer. 2003 Feb;36(2):121-8.

PMID:
12508240
28.

Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas.

Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker SJ.

Blood. 2003 Feb 15;101(4):1513-9. Epub 2002 Oct 3.

29.

Acute myelogenous leukaemia in older patients at St Bartholomew's Hospital: outcome with mitoxantrone and cytarabine.

Dalley CD, Lillington DL, Bradburn M, Carter M, Amess JA, Rohatiner AZ, Lister TA.

Hematol J. 2002;3(5):237-43.

PMID:
12391541
30.

High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours.

Lillington DM, Goff LK, Kingston JE, Onadim Z, Price E, Domizio P, Young BD.

Br J Cancer. 2002 Sep 23;87(7):779-82.

31.

Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides.

Mao X, Lillington D, Scarisbrick JJ, Mitchell T, Czepulkowski B, Russell-Jones R, Young B, Whittaker SJ.

Br J Dermatol. 2002 Sep;147(3):464-75.

PMID:
12207585
32.

Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis.

Mao X, Lillington D, Child F, Russell-Jones R, Young B, Whittaker S.

Genes Chromosomes Cancer. 2002 Oct;35(2):144-55.

PMID:
12203778
33.

Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization.

Strefford JC, Lillington DM, Steggall M, Lane TM, Nouri AM, Young BD, Oliver RT.

Cancer Genet Cytogenet. 2002 Jun;135(2):139-46.

PMID:
12127398
34.

Genetic susceptibility to Hodgkin's disease and secondary neoplasias: FISH analysis reveals patients at high risk of developing secondary neoplasia.

Lillington DM, Micallef IN, Carpenter E, Neat MJ, Amess JA, Matthews J, Foot NJ, Lister TA, Young BD, Rohatiner AZ.

Ann Oncol. 2002;13 Suppl 1:40-3.

PMID:
12078901
35.

11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop.

Bloomfield CD, Archer KJ, Mrózek K, Lillington DM, Kaneko Y, Head DR, Dal Cin P, Raimondi SC.

Genes Chromosomes Cancer. 2002 Apr;33(4):362-78.

PMID:
11921271
36.

Three further cases of t(8;14)(q11.2;q32) in acute lymphoblastic leukemia.

Byatt SA, Cheung KL, Lillington DM, Mazzullo H, Martineau M, Bennett C, Roberts K, Harewood L, Sumption N, Humphreys M, Burrett J, Harrison CJ.

Leukemia. 2001 Aug;15(8):1304-5. No abstract available.

PMID:
11480576
37.
38.

Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma.

Lillington DM, Micallef IN, Carpenter E, Neat MJ, Amess JA, Matthews J, Foot NJ, Young BD, Lister TA, Rohatiner AZ.

J Clin Oncol. 2001 May 1;19(9):2472-81.

PMID:
11331326
40.
41.

Molecular analysis of the genomic inversion and insertion of AF10 into MLL suggests a single-step event.

Chaplin T, Jones L, Debernardi S, Hill AS, Lillington DM, Young BD.

Genes Chromosomes Cancer. 2001 Feb;30(2):175-80.

PMID:
11135434
42.

Acute Myelogenous Leukaemia in Patients 60 Years and Older: A Retrospective Analysis from St Bartholomew's Hospital 1969-1999.

Dalley CD, Rohatiner AZ, Bradburn M, Lillington DM, Carter M, Slater S, MacCallum P, Amess JA, Lister TA.

Hematology. 2001;6(3):163-75. doi: 10.1080/10245332.2001.11746568.

PMID:
27420122
43.
44.

Cytogenetic and molecular evidence of marrow involvement in extramedullary acute myeloid leukaemia.

Lillington DM, Jaju RJ, Shankar AG, Neat M, Kearney L, Young BD, Saha V.

Br J Haematol. 2000 Sep;110(3):547-51.

PMID:
10997963
45.

Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies.

Micallef IN, Lillington DM, Apostolidis J, Amess JA, Neat M, Matthews J, Clark T, Foran JM, Salam A, Lister TA, Rohatiner AZ.

J Clin Oncol. 2000 Mar;18(5):947-55.

PMID:
10694543
46.

The cloning, mapping and expression of a novel gene, BRL, related to the AF10 leukaemia gene.

McCullagh P, Chaplin T, Meerabux J, Grenzelias D, Lillington D, Poulsom R, Gregorini A, Saha V, Young BD.

Oncogene. 1999 Dec 9;18(52):7442-52.

47.

More about: B-cell non-Hodgkin's lymphoma: evidence for the t(14;18) translocation in all hematopoietic cell lineages.

Apostolidis J, Lillington DM, Goff LK, Jones EL, Lister TA, Gupta RK.

J Natl Cancer Inst. 1999 Oct 6;91(19):1687-8. No abstract available.

PMID:
10511600
48.

The t(10;11)(p12;q23) translocation in acute leukaemia: a cytogenetic and clinical study of 20 patients. European 11q23 Workshop participants.

Lillington DM, Young BD, Berger R, Martineau M, Moorman AV, Secker-Walker LM.

Leukemia. 1998 May;12(5):801-4.

PMID:
9593284
49.

The t(6;11)(q27;q23) translocation in acute leukemia: a laboratory and clinical study of 30 cases. EU Concerted Action 11q23 Workshop participants.

Martineau M, Berger R, Lillington DM, Moorman AV, Secker-Walker LM.

Leukemia. 1998 May;12(5):788-91.

PMID:
9593282
50.

Supplemental Content

Loading ...
Support Center